特朗普政府削减了90%的肥胖药品价格,扩大了保险覆盖面,使其更容易获得。 The Trump administration cut obesity drug prices by up to 90% and expanded insurance coverage, making them more accessible.

特朗普政府宣布一项新协议, 大幅降低许多美国人肥胖药品成本, The Trump administration has announced a new agreement to significantly reduce the cost of obesity drugs for many Americans, with some prices slashed by up to 90%. 这项交易旨在扩大保险覆盖面,使减重药品更易于获得,标志着药品定价政策的重大转变。 The deal aims to expand insurance coverage and make weight-loss medications more accessible, marking a major shift in pharmaceutical pricing policy. 该倡议被誉为是寻求负担得起的治疗选择的病人的一项突破。 The initiative is being hailed as a breakthrough for patients seeking affordable treatment options.